Audrey’s Selected Meeting List for November 2007
Bio2Device Group, Tuesday Evening Meeting, Nov. 6, 2007
Topic: “Colonoscopy and the Avantis Solution”
Speaker: Fred Seddiqui, CEO, Avantis Medical
Date and Time: Tuesday, Nov. 6, 2007, 6:00 – 9:00 pm
Agenda
6pm - Light meal & Networking
7ish Program
8:30 Wrap-up Networking
Location: KeyPoint Credit Union Facility, 2805 Bowers Ave in Santa Clara.
No daytime meeting at NOVA
Must pre-register thru Acteva <http://www.acteva.com/booking.cfm?bevaID=145080>
For discounted registration fees, you must register before MIDNIGHT, Nov. 4th
Cost:
$11 members and guests who are employed
$6 for members and guests who are currently in transition
Late registration $20 after 12:01 am on Monday, Nov. 5th
$25 for walkins (on an as-available space basis)
Topic Description
Avantis Medical Systems, Inc. is a California-based medical device
company founded to develop and manufacture catheter-based endoscopic
devices. Its initial focus is on devices for use in both detecting and
treating cancers of the gastrointestinal (GI) tract. CEO Fred Seddiqui
will discuss the colonoscopy market and opportunities to improve
detection. Learn about Avantis' innovative device, the Avantis
Third Eye™ Retroscope™ and find out more about their clinical
studies and Center of Excellence Program.
Speaker Bio
Fred Seddiqui is CEO of Avantis Medical systems Inc. which develops and manufactures
catheters based endoscopic products. Mr. Seddiqui has over 18 years of executive
management experience in emerging companies in the high tech and life sciences
industries. From 1998 to 2002 he was President and CEO of Product Success, Inc., a
global service provider for the product development community with the initial target in
the Pharmaceutical, Biotech and Medical Devices market. Prior to Product Success, Inc.,
he was CEO of Fidus Medical Technology, a leading developer of a catheter-based,
microwave ablation system for treatment of major cardiac arrhythmias. Prior to AFx inc.,
Mr. Seddiqui was the CEO for four years of Medical Computer Imaging, Inc., a
cardiovascular diagnostic company. He was also co-founder of Microwave Coagulum
Treatment (MCT), a company dedicated to the treatment of breast tumors. Mr Seddiqui
is a graduate of the Stanford University Executive Management Program, Stanford
Business School.
Oct.29, 2007
1
German American Business Association (GABA), Thursday Evening, Nov. 8, 2007
Topic: Personalized Medicine, Companion Diagnostics, Biomarkers
Panel:
 Robert Schueren, Sr. Director Diagnostics Group, Genentech
 Werner Kroll, Novartis
 Eddie Moler, Tethys Bioscience
Date and Time: Thursday, November 8, 2007, 6pm-9pm
Agenda:
 6:00 - 7:00 pm Registration / Networking
 7:00 - 8:30 pm Program
 8:30 - 9:00 pm Networking / Reception
Complimentary appetizers, beer, wine and soft drinks will be served.
Location: Theravance, 901 Gateway Blvd., South San Francisco, CA 94080, (650) 8086000
Cost: $20 Members, $35 Non-Members, $50 at the door
RSVP: To RSVP, register and pay please use the link through http://www.gabanetwork.org/
http://www.gabanetwork.org/index.php?option=com_events&task=view_detail&agid=257&year=2007&
month=11&day=08&Itemid=116
Topic Description
Companion diagnostics and personalized medicine are no longer theory but rather near
future if not reality of today’s therapeutic approaches to treat cardiovascular and
neurological diseases as well as cancer, to name only some clinical areas. The approach is
to bring new drugs along with supporting tests to the market that will help physicians
make the decision for a specific drug prescription at a specific dose and help to evaluate
potential side effects on a patient to patient basis. A growing understanding of disease
underlying biological processes and increased opportunities in disease evaluation at the
molecular level by biomarkers, allows pharmaceutical and diagnostic companies
nowadays to characterize patients and disease and predict disease outcome and assess
disease prognosis better. We have invited speakers from pharmaceutical as well as
molecular diagnostic companies to provide you with expert insight into the area of
personalized medicine and biomarkers for companion diagnostics.
Topics for discussion after the panel talks will include:
 What can and what can’t be done by personalized medicine? ·
 What are biomarkers and how are they used in disease prediction and prognosis?
 How can biomarkers help in assessing how far a disease has already progressed
(disease staging) e.g. in diseases like cancer?
 What is the promise genomic and proteomic approaches hold for personalized
medicine?
 What are potential risks of personalized medicine?
 What are the socio-political consequences of personalized medicine?
Oct.29, 2007
2
RAPS San Francisco Bay Area Chapter, Friday Daytime, Nov. 9, 2007
Topic: “Clinical Trials Data Quality & Integrity”
Speakers:
Steve Fermi, Vice President, Clinical Affairs, Barosense Inc.
Jennifer Brunberg, Biostatistician & Senior Consultant, Alquest Inc.
Moderator: Anar Kotadia, RAC, Regulatory & Quality System Consultant
Date and Time: November 9, 2007, 11:00 am to 3:30 pm
Agenda
11:00am–12:00 pm Registration & Networking
12:00–1:00 pm Luncheon
1:00–3:00 pm Speaker Presentations
3:00–3:30 pm Q&A Session
Location: Crown Plaza Mid Peninsula,1221 Chess Drive, Foster City, CA 94404
+1 650 570 5700
Topic Description
Join RAPS San Francisco Bay Area Chapter for an engaging and informative
session on how to maintain quality and integrity of data during clinical trials. This session
also addresses some common mistakes that can lead to problems in study execution,
questionable data, and FDA regulatory or administrative actions.
Registration: Visit RAPS at www. RAPS.org/chapters <http://www.raps.org/chapters> to
register online or download a form to register by fax or mail.
Cost: RAPS members: $75; Non-members: $85
Cancellations: Cancellations are not accepted. Substitutions are welcomed with advance
notification. Applicable fees apply to substitute registrant.
Local Contact: Michelle Ragozzino, Ph.D., 1.408.861.3861
NorCal Pharma Product Management, Friday Evening, Nov. 9, 2007
Topic: "Project Management Model in a Non-Profit Pharmaceutical Company"
Speakers from the Institute for OneWorld Health:
 Lauren Thorner, PhD, Director Project Management Diarrheal Disease Program
 Autumn Ehnow, Senior Project Manager, Malaria
 Kelly Oliver, Sr. Project Manager, Visceral Leishmaniasis
Date and Time: Friday, Nov. 9, 2007 from 8 am to 10 am
Location: Genentech, Building 32, conference room A (right behind the reception desk)
at 1541 Grandview Avenue (aka DNA way).
Please RSVP at www.pharmalig.org. to get the proper badges and
parking spaces.
Bio2Device Group, Tuesday Morning, Nov. 13, 2007
Speaker: TBD
Topic: TBD
Date and Time: Tuesday, Nov. 13th, 8:30 am to 10:30 am
Oct.29, 2007
3
Location: NOVA, 505 West Olive, Sunnyvale, Room 510
Cost: Free
See details at www.bio2devicegroup.org
GGPF & Bay Area Mass Spectrometry (BAMS) Meeting, Tuesday Evening, Nov. 13
Topic: "Structural Characterization of PEGylated Protein Therapeutics using Gas-Phase
Ion/Molecule Chemistry and Ion Mobility Tandem Mass Spectrometry"
Speaker: Paul Schnier Department of Molecular Structure, Amgen, Thousand Oaks, CA
Location: Michael's Restaurant at Shoreline Park, Mountain View
Date and Timing: Tuesday, Nov. 13, 2007
6:00 PM social hour
7:00 PM dinner
8:00 PM presentations begin
Cost: $30 with advance registration
Half price for students, retired, and unemployed. (late fee still applies, if applicable)
Free if you attend just the lectures at 8:00 PM. (but please let us know for headcount)
$40 after registration deadline, if possible -- please contact us to inquire.
Deadline for registration: 5 PM Friday, Nov. 9 (but please try to do so earlier if you can;
it helps) Please register on the web page
Topic Description
Conjugation of polyethylene glycol (PEG) to a protein therapeutic can safely improve
pharmacokinetic properties, thus PEG and its derivatives have found wide application in
the biopharmaceutical industry. PEGs used in these applications are typically
polydisperse and generally of high molecular weight, obfuscating direct analytical
characterization. Here, we demonstrate the use of ion mobility in the separation of PEGs
of different chain length, facilitating direct measurement of MW and polydispersity of
pegylated peptides/proteins. Ion-molecule proton-transfer chemistry, in either the ion
mobility cell or source, can be used to enable charge stripping of the PEG ions in order to
further simplify the spectrum. Tandem mass spectrometry of the mobility separated ions
allows the site of PEGylation to be unambiguously determined. Additionally, a novel
functional analysis algorithm to quantitatively compare the 3D topology of ion mobility
MS spectra has been developed. This approach allows for the direct quantitation of low
level impurities and degradation products present in these samples; this methodology can
be used in a high throughput fashion to fingerprint heterogeneous PEGylated
therapeutics. For these applications, ion mobility coupled with mass spectrometry offers
several analytical advantages over mass spectrometry alone, including enhanced dynamic
range, increased sensitivity and specificity.
Speaker Bio
Paul Schnier received his Ph.D. in Physical Chemistry from the University of California,
Berkeley, in 1998, followed a by post-doctoral fellowship at the Oak Ridge National
Laboratory. He has worked in the biopharmaceutical industry for the last eight years, and
is currently Principal Scientist in the Department of Molecular Structure at Amgen. His
Oct.29, 2007
4
current research interests are focused on the application of novel mass spectrometric,
NMR, and biophysical methodologies to drug discovery.
A Technology Ventures Corporation Event, Tuesday Morning, Nov. 13, 2007
Topic: “Seminar #5: Operations Start-up, Monitoring & Human Resources” (Menlo Park)
Date: Tuesday, Nov. 13th
Time: 8:30am-12:30pm
Location: SRI International, 333 Ravenswood Avenue, Menlo Park
Pricing: Free event. You do not need to be entrepreneur to attend.
Description:
Most technology entrepreneurs are visionaries who spend 99% of their time and energy
developing and honing their technology solutions for customers. That doesn't leave much
for the critical support activities that will evolve into the venture's infrastructure. Join us
for a discussion about the "back-office" activities of a start-up effort, especially those that
involve ownership and compensation of your co-founders, employees, and contractors.
Cost - FREE
Call 925-960-1600 if you have any questions
Register at www.123signup.com/calendar?org=techventures.
For more information, contact TVC at 925.960.1600 or
tvc.ca@techventures.org . Note website often has errors like saying open in one place
and closed in another. Go to register section which is usually in order. You can also call
about being on waiting list.
When it comes to managing your career, you can never have too much information.
On Wednesday, November 14, join Science Careers, Bay Bio, and career expert Dave
Jensen for "Up the Biotech Corporate Ladder," a seminar detailing proven strategies for a
successful career in biotech.
In addition to Dave’s expert advice, you’ll get first-hand stories of success in the biotech
industry from Dr. Jennie Mather, Founder and CSO of Raven Biotechnologies, and Doug
Buckley, VP Biochemistry at Exelixis.
Registration is required and space is limited so reserve your spot today.
ROXRO Pharma and SRI, Café Scientifique, Tuesday Evening, Nov. 13, 2007
Topic: “Migraine, Stress and Peanut M&Ms”
Speaker: Stephen J. Peroutka, MD and Ph.D., Independent Consultant
Date and Time: Nov. 13, 6-7:30 pm
Location: SRI Menlo Park, Middlefield Road at Ringwood - Dining Room in the
International Building
Café Scientifique events are open to all free of charge. No reservations are
necessary. For more information please visit our web site: http://www.cafescisv.org/ .
Topic Description
Oct.29, 2007
5
Migraine affects approximately 30 million people in this country, typically adults
between the ages 25 and 55. Seventeen percent of all women experience a migraine
headache at some time, an incidence rate three times higher than for men. Migraine is
characterized by throbbing pain, usually located on one side of the head, often
accompanied by nausea and sensitivity to light and sound. For migraine sufferers, the
effects are substantial. Over half of migraineurs are severely impaired or require bed rest
during attacks. The National Headache Foundation estimates that 157 million workdays
are lost annually due to migraine.
Speaker Bio
Stephen J. Peroutka is a neurologist and pharmacologist whose research in migraine
spans 25 years. Peroutka will discuss how his research into the genetic basis for migraine
led him to surprising data regarding the role of insulin receptors. He will also discuss his
resulting conclusions on ways to deal with migraine, including factors that trigger the
onset of migraines and the usefulness of peanut M&Ms. Peroutka received his M.D. and
Ph.D. degrees in 1979 and 1980, respectively, from the Johns Hopkins University School
of Medicine. After completing an internship at Stanford in 1981 and a residency at Johns
Hopkins Hospital, he was an Assistant Professor of Neurology and Pharmacology at
Stanford from 1984-1990 and was Chief, Neurology Service, at the Palo Alto VA
Hospital from 1988-1990.
In 1990, he joined Genentech, Inc. where he established the Department of Neuroscience
and became its first Director in 1991. In 1993, he founded Spectra Biomedical, Inc., an
association genetics company focused on migraine. In June, 1997, Spectra Biomedical,
Inc. was acquired by Glaxo Wellcome Inc. Subsequently, he has been an independent
consultant to the pharmaceutical and biotechnology industries. He was Chief Medical
Officer at Collabra Pharma in 2000-2001, Vice President of Clinical Research at
Deltagen, Inc. in 2001-2002 and President and CEO of Synergia Pharma, Inc. from 20032005. Most recently, he was the Franchise Development Leader for Pain at Johnson &
Johnson. He also founded The Physician Genome Partnership, an Internet-based group
of international physicians dedicated to interpreting the clinical relevance of the human
genome.
Coffee, tea and biscotti will be complimentary, provided by SRI - Bring your own mug if
you wish to avoid using disposable cups.
A Technology Ventures Corporation Event, Wednesday Morning, Nov. 14, 2007
Topic: “Seminar #5: Operations Start-up, Monitoring & Human Resources””
(Pleasanton)
Date and Time: Wednesday, Nov. 14, 8:30 am-12:30pm
Location: Carr America Conference Center, 4400 Rosewood Drive, Pleasanton
Website: Contact 925-960-1600 if you have any questions
Register at www.123signup.com/calendar?org=techventures
Pricing: Free.
For more information, contact TVC at 925.960.1600 or
Oct.29, 2007
6
tvc.ca@techventures.org . Note website often has errors like saying open in one place
and closed in another. Go to register section which is usually in order. You can also call
about being on waiting list.
Description:
Most technology entrepreneurs are visionaries who spend 99% of their time and energy
developing and honing their technology solutions for customers. That doesn't leave much
for the critical support activities that will evolve into the venture's infrastructure. Join us
for a discussion about the "back-office" activities of a start-up effort, especially those that
involve ownership and compensation of your co-founders, employees, and contractors.
San Francisco AWIS, Wednesday Evening, Nov. 14, 2007
Topic: November Networking Social
Date and Time: Wed., Nov. 14, 6:30-8:00 pm
Location: The Pub at UCSF, Mission Bay, 1675 Owens St., San Francisco
Cost: Free
Registration: None required
Maps and directions
Reduced evening parking rates in UCSF surface lots only
Be a part of sfAWIS' cozy and diverse bimonthly Networking Socials--conveniently
located at UCSF's new Community Center and Pub.
All scientists, students, and friends welcome!
Science Careers and Bay Bio, Career Seminar, Wednesday Evening, Nov. 14, 2007
Topic: “Up the Biotech Corporate Ladder”
Seminar Leader: Dave Jensen and Speakers: Jenny Mather, Founder and CSO of Raven
Biotechnologies and Doug Buckley, VP of Biochemistry at Exelixis
Date and Time: Wednesday, Nov. 14, 5:30 to 7:30 pm
Location: UCSF Mission Bay Campus, Genentech Hall, San Francisco, CA
See http://php.aaas.org/scheduler/meetings.php for registration
Cost: None
Topic Description
A seminar detailing proven strategies for a successful career in biotech. In addition to
Daves expert advice, youll get first hand stories of success in the biotech industry from
Dr. Jennie Mather, Founder and CSO of Raven Biotechnologies and Doug Buckley, VP
of Biochemistry at Exelixis. Registration is required and space is limited so reserve your
spot now.
PDA West Coast Chapter Dinner Meeting Series: Thursday Evening, Nov. 15, 2007
Topic: “Current Biopharmaceutical CMC Issues - What PDA is Doing and How You Can
Help” and Chapter Member Appreciation Night
Oct.29, 2007
7
Speaker: John Geigert, PhD., RAC, BioPharmaceutical Quality Solutions
Date and Time: November 15, 2007, 7:00 - 10:00PM, Treasure Island Commodore,
Alameda, CA
Join the PDA West Coast Chapter aboard the Treasure Island Commodore luxury yacht
on San Francisco Bay for an evening of cruising, dining, and networking while enjoying
stunning views and a current topic presentation. The TIC tri- maran is known as “The
Floating Glass Restaurant of San Francisco Bay" because it literally has floor-to-ceiling
glass on the dining deck. The cruise will depart from the Alameda Mariner Square
Marina. This special end-of-year event is to celebrate and thank our chapter members for
their support during 2007. Seating is limited to 80 attendees, so register now if you plan
to attend!
Agenda
6:45 PM Boarding, Registration, and Hosted Reception
7:00 PM Underway!
7:15 PM Dinner Buffet
8:15 PM Announcements
8:30 PM Presentation and Discussion
9:45 PM Disembarking
Topic Description
Dr. Geigert will share challenges faced by the biopharmaceutical industry and describe
what the Biotech Advisory Board and PDA Task Forces are doing to address them.
Topics will include Mycoplasma issues in plant-derived materials, analytical assay
development, EMEA proposed viral clearance studies for clinical trials, and
standardization of viral removal nanofilters.
Speaker Bio
Dr. Geigert has over 25 years experience in Chemistry, Manufacturing & Control (CMC)
strategies for the development of biopharmaceutical and biological medical products. He
has demonstrated successful CMC leadership for moving six drug products (Recombinant
IFN-beta, IL-2, GM-CSF and TNFR; Monoclonal Antibodies Rituxan and Zevalin) from
clinic into market approval with both the FDA and EMEA. He served for 10 years as
Vice President of Quality (Immunex - now Amgen, IDEC - now Biogen IDEC). He has
consulted since 2001 with emphasis on CMC regulatory strategy and assessment of
quality systems. He is Regulatory Affairs Certified (RAC) by the Regulatory Affairs
Certification Board; a past Member of USP Expert Committee on Biotechnology, Natural
Products & Diagnostics, 2000-2005; and past co-chair of the PDA Biotechnology
Advisory Board, 2004-2007. He is the author of The Challenge of CMC Regulatory
Compliance for Biopharmaceuticals, Plenum Press, New York (2004).
Dinner Menu
• Caesar salad
Oct.29, 2007
8
• Chicken with creamy mushroom and grape sauce or Prime rib served with pink
peppercorn demi-glace
• Saffron wild rice pilaf and roasted seasonal vegetables
• Dessert, coffee, tea, etcNote: A vegetarian meal is available upon request.
Registration
Submit your registration request to rsvp@wccpda.org. Seating to this special event is
limited to 80 attendees and space is only guaranteed via payment in advance! The event
fee covers dinner, host bar, presentation, and a leisurely cruise around the San Francisco
Bay.
Cost: PDA Members: $65Non- Members: $80 Not a member? Sign-up now at PDA!
Payment OptionsWCC PDA can only accept payments via personal or corporate check
for this event. Please make check payable to "WCC-PDA" and include the names of the
attendee(s) on the stub. Mailing address will be provided in reply to your RSVP.
Cancellation Policy: Dinner seating is reserved and confirmed in advance. We regret that
absolutely no refunds can be offered for non-attendance. If a registrant is unable to attend,
substitutions are welcome.
Driving Directions to Commodore Events LEAVE EARLY.Allow for unexpected traffic
congestion.
2394 Mariner Square Drive, Alameda, CA 94501
FROM SAN FRANCISCO:Take the Bay Bridge and exit to the right following the sign,
880/Alameda/San Jose. Go 2.5 miles and exit Broadway/Alameda. Turn right on Fifth St.,
go through six lights and from the left two lanes, cross Broadway and follow the
Alameda sign into the Webster tube to Alameda. After exiting the Webster tube, take the
first right exit onto Mariner Square Drive. Follow the loop around to the first stop sign
and turn left on Mariner Square Dr.FROM FREMONT/SAN JOSE:Take 880 North. Exit
Broadway in Oakland. Turn right on Broadway Go two blocks and turn right on Seventh.
Go two blocks and turn right on Webster. Follow the sign to Alameda. After exiting the
tunnel take the first right exit onto Mariner Square Loop. Follow the loop around to the
first stop sign and turn left on Mariner Square Dr.FROM BERKELEY AND VALLEJO
AREAS:From I-80, as you approach the Bay Bridge, follow the center lanes and the sign
to Alameda/San Jose. Go three miles and exit Broadway/Alameda. Turn right on Fifth St.
Go through six lights and from the left two lanes, cross Broadway and follow the
Alameda sign into the Webster tube, take the first right exit onto Mariner Square Loop.
Follow the loop around to the first stop sign and turn left onto Mariner Square Dr.FROM
WALNUT CREEK AREA:Take 24 to west I-980. Exit 11th/12th Street. This becomes
Brush. Turn left on Seventh St. At the sixth stop light, turn right on Webster. Continue on
Webster and follow the sign to Alameda. After exiting the tunnel take the first right exit
onto Mariner Square Loop. Follow the loop around to the first stop sign and turn left onto
Mariner Square Dr.PARKING:The foot of Mariner Square has limited parking that is
reserved for the two restaurants there. You may park on both sides of Mariner Square
Drive and there is reserved yacht guest parking in the spaces in front of and behind the
Mariner Square Office complex at the head of Mariner Square Drive. It's a short walk to
the yachts at the foot of Mariner Square Drive. Of course, you may drop your passengers
at the foot of the drive, particularly those with disabilities, and come back to
park.GOING HOME:Proceed up Mariner Square Dr. to the stop sign. Go straight; one
Oct.29, 2007
9
long block and turn right onto the street that carries you into the Posey Tube. Be in the
right hand lane, exiting, and follow signs toward San Francisco to I-80 East or West or 24
toward Walnut Creek. For I-880 South, follow the sign to San Jose.
Palo Alto AWIS, Thursday Evening, Nov. 15, 2007
Topic: From Biology to Cure: Hematopoietic Stem Cells from Cord Blood
Speaker: Prof. Rajni Agarwal, Stanford University
Date and Time: Thursday, November 15, 2007, 7:00 to 9:00 pm
Schedule
7:00-7:30 pm Networking and light supper
7:30-7:45 pm
Announcements
7:45-8:45 pm
Program
8:45-9:00 pm
Discussion
Location: PARC Auditorium, 3333 Coyote Hill Road , Palo Alto
RSVP: online http://www.acteva.com/go/pa-awis
Topic Description
Have you seen the advertisements about cord blood banks and found yourself wondering:
what is it about and how crucial is it for you and your family? We did, so we decided to
ask an expert in the field. Please join us as Dr. Agarwal-Hashmi shares with us some of
the exciting ways that stem cells are being used therapeutically today.
Speaker Bio
Our next speaker for AWIS will be Dr. Agarwal-Hashmi, a clinician and researcher at
Stanford University. Dr. Agarwal-Hashmi's research experience began at the NIH, where
she developed stem cell assays and in vivo models critical to understanding stem cell
biology and its clinical implications. Upon moving to Children's Hospital Medical
Centre (CHMC) in Cincinnati, Dr. Agarwal-Hashmi established her research laboratory
to further investigate the field of hematopoietic stem cells, specifically using umbilical
cord blood. At CHMC, Dr. Hashmi also pioneered the clinical umbilical cord blood
transplant program.
Welcome!! This Meeting is free. You don't need to be a member to attend.
All scientists, students, and their friends are welcome. Men too!
We ask for a $3 donation to offset the cost of food.
Free China Business Forum, Thursday Evening, Nov. 15, 2007
Topic: “China: What’s different? What’s changing? What are the best companies doing
about it right now?”
Speakers: Alan Carroll, Executive Chairman, Pacific Rim Forum and Andrew Gilkes,
Executive Director, China Access 2008 (I’ve attended one of Gilkes events found it
interesting but consider that the source is a paid employee to promote business in China)
Date and Time: Thursday 15th November from 5.00pm to 6.30pm (followed by drinks
and networking).
Oct.29, 2007
10
Agenda
5 – 5:30 pm
“The Ten Most Critical Insights about China That Will Help You Succeed in
Business”
5:30– 6 pm
“The 10 ‘Better Questions’ To Design Your Corporate Strategy in China 2008 –
2010”
6 – 6:30 pm
A panel discussion of the key strategic and operational issues being faced by foreign
companies in China today – and how these companies are dealing with them.
6:30 – 7:30 pm
No host bar and professional networking
Location: Axis Café, 1201 8th Street, San Francisco, www.axis-café.com (Tel: 415 437
2947)
Registration: A formal registration to attend is not required.
Topic Description
This past week’s 17th China Communist Party Congress, convened once every 5 years, is
an important event in Chinese politics and has determined both the Chinese leadership for
the coming period and much of the country’s future direction. The forum will focus on
these and other political and economic developments and their likely impacts on
business. The forum is being convened by China Access 2008, the international business
facilitation network of the Beijing 2008 Olympic Games (www.chinaaccess2008.com).
Speaker Bios
Alan Carroll is a strategic management specialist with a specific focus on China that has
been built over the past two decades. During this time, Alan has worked closely with
major multinational companies to develop and better execute their Asian strategies. Alan
is the Founder and Executive Chairman of the Pacific Rim Forum, Asia Pacific’s
“thought leader” business event. There have been 10 Forums throughout the region
during the past 16 years and the next Pacific Rim Forum is scheduled for Beijing in
August, 2008.
Andrew Gilkes has over 20 years experience in international business including senior
positions with Westpac Banking Corporation, one of Australia’s leading financial
institutions. In 1997 he left banking to become Chief Executive of Investment 2000, the
newly created economic ‘legacy’ program for the Sydney 2000 Olympic Games. In the
ensuing three years Andrew led a team that designed and implemented a highly
successful international business marketing program that attracted over 50 new
businesses to Australia. The venture received widespread recognition as a world best
practice. Andrew is currently working with China to leverage lessons learned from
Sydney for Beijing 2008 and Shanghai 2010.
Oct.29, 2007
11
Fountain Blue Life Sciences Entrepreneur Forum, Monday Evening, Nov. 19, 2007
Topic: “Building An A+ Life Science Management Team”
Facilitator, Roy Fiebiger, Managing Partner, Sanford Rose Associates
Panelists:
Chuck Brynelsen, CEO of IntraPace
Panelist, Dan Galles, General Partner, HLM Venture Partners
Panelist, Jonathan Goldman, MD
Other Panelists to be confirmed
Date and Time: Monday, Nov. 19th, 5:30 – 7:30 pm
Location: DLA Piper, 2000 University, East Palo Alto, CA. To pre-register for the
discounted rate of $18-$25, visit http://www.acteva.com/booking.cfm?bevaid=121447 by
noon on Friday, November 16. A limited amount of on-site registration is available for
$40, on a first-come, first-served basis.
Information and Registration: NO SERVICE PROVIDERS PLEASE.
* Additional information about our life science entrepreneurs' forum is available at
<http://www.fountainblue.biz/entrepreneurevents/lifescienceentrepreneur.html Join the
Life Science community by visiting
http://finance.groups.yahoo.com/group/SVLifeScience .
Topic Description
There's a big difference between having a good idea in the right market at the right time
and starting and running a successful company, in the life science or any other industry.
The key ingredient is having a team with the background, expertise and connections to
execute a plan and make the company successful.
Bio2Device Group, Tuesday Morning, Nov. 20, 2007
Topic: Thanksgiving break
Bio2Device Group, Tuesday Morning, Nov. 27, 2007
Speaker: Mostafa Ronaghi of Stanford Genome Technology Center
Topic: TBA
Date and Time: Tuesday, Nov. 27, 8:30 am to 10:15 am
Location: NOVA, 505 West Olive, Sunnyvale, Room 510
Cost: Free
See details at www.bio2devicegroup.org
East Bay Association for Women in Science, Thursday Evening, Nov. 29, 2007
Topic: “Using science and technologies for environmental and health problems in developing
countries”
Oct.29, 2007
12
Speaker: C hri st i na Ga l i t sk y, Staff Research Associate, International Energy Studies Group,
Environmental Energy Technologies Division, Ernest Orlando Lawrence Berkeley National
Laboratory
Date and Time: Thursday, Nov. 29th, starts at 6:30 pm with light supper; 7:00 meeting begins
Location: Novartis Room 4.104, 4560 Horton St. Emeryville, CA
Cost: Suggested donation to cover the cost of food, $10 non-members or $5 memb
Scientists and Science Enthusiasts, Men and Women, And non-AWIS members are Welcome!
Speaker Bio
Christina Galitsky is a Staff Research Associate in the International Energy Studies
Group, Environmental Energy Technologies Division at Lawrence Berkeley National
Laboratory. She received her Master’s in Chemical Engineering from the University of
California, Berkeley in 1999 and her Bachelor’s in Chemical Engineering from the
University of Pennsylvania in 1996. Current research focuses on sustainable development
projects in developing countries such as developing a fuel efficient cookstove program in
Darfur, Sudan, and development of energy efficiency and benchmarking tools for China.
Other research includes identifying and assessing opportunities for greenhouse gas
emissions reductions in several industrial sectors, developing user-interfaced tools for
estimating energy use and efficiency potentials, and providing technical support for
several programs. In 2006, she was named one of MIT Tech Reviews Top Inventors
under 35.
*NOVARTIS security procedures requires check in at the guard station prior to
parking
Public transit: Take BART to McArthur and FREE Emery-go-round
(www.emerygoround.com) Hollis Bus to Novartis or take AC transit Bus #19
Oct.29, 2007
13